Bioverse review
⛔ FDA warning letter #716508 (Sept. 2025), which names gobioverse.com. A broader longevity platform (TRT, sexual health, hair loss and skin, alongside GLP-1) advertising a consistent $129/mo semaglutide and $399/mo tirzepatide — sitting next to a genuinely unresolved defect: its own homepage FAQ lists two different, non-matching sets of served states in two different answers on the same page.
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
Bioverse at a glance
- Semaglutide
- $129/mo
- Tirzepatide
- $399/mo
- Coverage
- Two conflicting FAQ lists on Bioverse's own homepage — one names 10 states, another names 18 — confirm your own state directly
- Brand-name
- Compounded only
How we scored Bioverse
Each score comes out of Bioverse's published pricing, disclosures and oversight, and the six combine into the 46/100 Editors' Rating on the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
The headline rate obscures a plan requirement or a hidden step-up.
Little here is shaped around a mother's week or her life stage.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
⛔ Added 26 August 2026: Bioverse, Inc. dba Bioverse holds FDA warning letter #716508, dated 9 September 2025. A screen of the WHOLE roster against the live FDA index (3,664 letters, self-test green) turned it up — not a brand-name search — and we confirmed it by reading the letter, which names gobioverse.com. This review had been published for months without mentioning it. A letter discloses; it does not disqualify, and nothing about the ranking changed. $129 for semaglutide and $399 for tirzepatide — an unusually wide spread between two molecules. Confirm your state before paying: two FAQ answers on the same homepage name ten states and eighteen. GLP-1 is one line on a broader longevity platform that also sells TRT, hair and skin.
What to expect when you sign up
We walked Bioverse's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Separate product pages exist for semaglutide and tirzepatide, each showing the struck-through list price alongside the current advertised price twice on the page
- 2GLP-1 is one line among a broader longevity/telehealth menu that also covers TRT, sexual health, hair loss and skin
What we noticed
- Bioverse's own homepage carries two different state-coverage lists in two different FAQ answers on the SAME page: one names 10 states (Florida, Texas, New Jersey, Michigan, Ohio, Pennsylvania, Washington, Virginia, North Carolina, Indiana), the other names 18 (adding Arizona, California, Colorado, Georgia, Illinois, Maryland, Massachusetts, New York among others) — we disclose both rather than silently pick one
- No named medical group, compounding pharmacy or individual clinician found on the pages checked
- Bioverse, Inc. dba Bioverse holds FDA warning letter #716508 (9 September 2025); the letter names gobioverse.com, though nothing on the pages we walked mentions it
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $129 | Current advertised rateShown as "Starting at $289 $129/mo," list price struck through to the advertised rate, repeated consistently in two places on the product page — not a one-off promo banner. |
| Compounded tirzepatide | $399 | Current advertised rateShown as "Starting at $449 $399/mo," list price struck through to the advertised rate, repeated consistently in two places on the product page. |
Swipe the table to see plan details →
GLP-1 telehealth is usually HSA- and FSA-eligible, so check your own plan. Everything above comes from Bioverse's public disclosures at last review and change often; confirm the current number on Bioverse's own site.
What we like
- $129/mo semaglutide is among the lower current, standing (not promo-only) prices in this batch
- The advertised price is shown consistently in two places on each product page, not buried in a single fine-print banner
- List-price-to-sale-price framing is at least shown transparently, with both numbers visible side by side
The caveats
- ⛔ FDA warning letter #716508, dated September 9, 2025, to Bioverse, Inc. dba Bioverse, for unlawful sale of unapproved and misbranded drugs over the internet — the letter names its own site
- Publishes two different state-coverage lists in two different FAQ answers on the exact same homepage — 10 states in one, 18 in the other — and never reconciles them
- Broader longevity/telehealth platform (also TRT, sexual health, hair loss, skin) — GLP-1 is one line among several, not the focus
- No named medical group, compounding pharmacy, or individual clinician found on the pages checked
- No stated inclusion of consult, labs, or shipping in the advertised price — not disclosed either way
- No mention anywhere of pregnancy, breastfeeding, or postpartum care
Bioverse for mothers: our verdict
⛔ FDA warning letter #716508 (Sept. 2025), which names gobioverse.com. A broader longevity platform (TRT, sexual health, hair loss and skin, alongside GLP-1) advertising a consistent $129/mo semaglutide and $399/mo tirzepatide — sitting next to a genuinely unresolved defect: its own homepage FAQ lists two different, non-matching sets of served states in two different answers on the same page. It runs about $129/month — toward the affordable end of what we track.
We weigh Bioverse the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.
What Bioverse actually costs
- Compounded semaglutide — Current advertised rate: $129/mo
- Compounded tirzepatide — Current advertised rate: $399/mo
That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications Bioverse prescribes
Bioverse prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where Bioverse fits — and where it doesn't — for mothers
Worth it if…
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Give it a miss if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
One line that applies to every provider on this masthead: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Bioverse is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Mothers already comfortable with a general longevity-telehealth platform and an appealingly low semaglutide price, who will confirm their own state directly given the site's two conflicting FAQ answers.
Alternatives to Bioverse
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing Bioverse
Head-to-head & alternatives
Bioverse, answered
- Does Bioverse serve my state?
- We can't give you a settled answer, because Bioverse's own homepage can't either. Two different FAQ answers on the SAME page list two different sets of states — one names 10, the other names 18, and they don't nest cleanly inside one another. Rather than guess which one is current, we're publishing both and telling you to confirm your own state directly with Bioverse before you pay for anything.
- Is $129/mo the real price for semaglutide?
- Yes, as far as we can verify — it's shown consistently in two places on Bioverse's own semaglutide product page, not a one-time banner, struck through from a $289 list price. Tirzepatide follows the same pattern at $399/mo, down from $449. Both are the current, standing advertised rates, not a first-month-only teaser.
Pricing, states and verification reflect Bioverse's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.